Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function.
about
The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cellsSignificant increase in cytotoxic T lymphocytes and natural killer cells by triphala: a clinical phase I studyThe Global HIV/AIDS Vaccine Enterprise: scientific strategic planIn vivo assessment of natural killer cell responses during chronic feline immunodeficiency virus infectionInsufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cellsAlcohol suppresses IL-2-induced CC chemokine production by natural killer cells.Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads.Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection.Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity.Genetic characterization of HIV-1 from semen and blood from clade C-infected subjects from India and effect of therapy in these body compartments.Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individualsHIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.Mucosal correlates of protection in HIV-1-exposed sero-negative persons.Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?Innate immune natural killer cells and their role in HIV and SIV infection.Alterations of natural killer cell and T-lymphocyte counts in adults infected with human immunodeficiency virus through blood and plasma sold in the past in China and in whom infection has progressed slowly over a long period.Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity.Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothersNatural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.Changes in Natural Killer cell activation and function during primary HIV-1 Infection.High frequencies of polyfunctional CD8+ NK cells in chronic HIV-1 infection are associated with slower disease progressionNatural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infectionSimian immunodeficiency virus (SIV)/immunoglobulin G immune complexes in SIV-infected macaques block detection of CD16 but not cytolytic activity of natural killer cellsNatural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment.T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus.Activation of NK cells by ADCC antibodies and HIV disease progression.Effects on innate immunity of a therapeutic dendritic cell-based vaccine for HIV-1 infectionHigher Frequency of NK and CD4+ T-Cells in Mucosa and Potent Cytotoxic Response in HIV Controllers.Control of HIV-1 infection by soluble factors of the immune response.DCs and NK cells: critical effectors in the immune response to HIV-1.Increased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression.Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assaysRelationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individualsInnate immune defenses in HIV-1 infection: prospects for a novel immune therapy.
P2860
Q21144323-68657053-68B9-4F31-BB9C-E2DB31E43ABCQ21296692-D429E8A0-68B4-454B-B48F-AAD66916F019Q21563445-FB4BC35F-626C-4F41-942B-72BDD8F4BC28Q27302300-4808860B-32C4-439D-BEDE-E5B0959398C6Q28068375-B8026FB4-01C2-4649-BBFB-9D6863D19A27Q33586473-817E705C-A241-4D15-B05D-7CD07A7D2D7BQ33609877-C182B763-E342-4F5E-AD6C-06E93339E3F7Q33686528-658F40B2-D5F8-423E-BDBF-681732DC5FEAQ33772422-5FE142E3-A061-4695-84BB-3AC10C799979Q33786292-35124648-9881-43F3-BFF3-CA36466C485CQ33842057-99082E46-1FEE-4AE5-AB30-695F1F28F8C5Q33858471-F16F6FC4-F723-4BF5-B9D0-02C97C883F12Q33864775-67C5FD27-D52C-4B08-A9D0-296BCAB19A9DQ33887674-38CCF7E4-7A7E-46E9-9063-3C2C66319652Q33911540-AE9E1B7F-55B3-44EB-A6FD-BA9CBF7683CDQ33992829-D847C695-9202-4D0E-B45A-60890EC1BA10Q34070433-57059A10-EC45-422B-BA55-D5F0B089EE69Q34143509-7919EC97-D7DB-47EB-A550-9209725B32B5Q34150316-C997349E-F2AA-4C56-9D84-324D6CDEB073Q34310322-6CF3B539-6B4D-479A-B79C-52A8F434B35BQ34389699-F54E7C6C-C75D-4975-ABE3-72236EEC1EA3Q34434825-5782A633-62B6-4452-86E8-2FDEF3F07BF2Q34551274-711E18FF-EF41-4FB8-B08E-F38159008808Q34593740-511296A1-E201-409E-9616-16CED835E9EBQ34694776-213E4FD9-4E37-40EE-9456-5B35A7F024F6Q34720432-CD5DC9B4-985D-4D79-A664-A54606FA99E7Q34741864-BA5C22B0-6F63-49CA-A9BC-993542AC2C50Q35076703-8CB8320A-72DB-4C3B-B897-8D16940CEA79Q35096435-D26BFFA0-B3C9-428D-9297-0E2358F7F8EDQ35216404-01B16E6B-CBAF-4147-88E8-102B55156152Q35218850-D1A19F06-539D-4F4B-9BAA-6577801FAA83Q35731394-3A3F488C-459F-4BD6-8D48-E8CF41EF2427Q35751335-686272A1-94B4-4F3D-956D-D0B23E1438FDQ35752416-6287F716-A865-450B-A131-142E929BE56DQ35752667-74464A33-E59F-446C-9260-F947B7F39CDBQ36246252-AE7CB265-2017-4314-A130-AD8AC4618750Q36304297-9CF22691-3745-41DE-A28D-32EE9CC98AADQ36363866-606666EF-B2EC-4020-B6F1-A0BFDE3AC8EDQ36602397-2CCD652E-DF11-48CF-825A-A56553B49D78Q36670882-19252600-0EBC-4B6F-BDC7-FF6385B9B4D0
P2860
Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Innate immunity in human immun ...... natural killer cell function.
@en
Innate immunity in human immun ...... natural killer cell function.
@nl
type
label
Innate immunity in human immun ...... natural killer cell function.
@en
Innate immunity in human immun ...... natural killer cell function.
@nl
prefLabel
Innate immunity in human immun ...... natural killer cell function.
@en
Innate immunity in human immun ...... natural killer cell function.
@nl
P2093
P50
P356
P1476
Innate immunity in human immun ...... natural killer cell function.
@en
P2093
Frank Maldarelli
Lawrence Corey
Mary McLaughlin
Shuying Liu
P304
P356
10.1086/368222
P407
P577
2003-03-13T00:00:00Z